A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis
Science Advances · 14.03.2025 · 11 (11)
DOI: 10.1126/sciadv.adt0341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.03.2025. Verfasst von Zheyu Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Cancer Vaccines, Bacterial Vaccines, Breast Neoplasms, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Specific bacteria, including Fusobacterium nucleatum , Streptococcus sanguis , Enterococcus faecalis , and Staphylococcus xylosus , have been identified as contributors to breast cancer metastasis. Due to limitations such as lack of selectivity, traditional antibiotic therapies face obstacles in eliminating intratumoral bacteria. Herein, this work proposes the use of therapeutic vaccines to selectively target and eliminate harmful bacteria within tumors. A multivalent vaccine encapsulating both insoluble and soluble bacterial antigens was developed, addressing the shortcomings of traditional antibacterial vaccines by balancing broad antigen coverage with effective immune activation. This vaccine induces robust downstream immune responses to eliminate F. nucleatum , S. sanguis , E. faecalis , and S. xylosus , demonstrating notable therapeutic and preventive efficacy in bacteria-induced cancer metastasis models. Unexpectedly, vaccinated infected mice showed even slower tumor metastasis than uninfected mice. Overall, this study validates the potential of nanovaccines in modulating the intratumoral microbiome for tumor therapy and highlights tumor-associated bacterial infections as potential promising antitumor targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
- School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.
ORCID-Profile: Zheyu Kang, Linfu Chen, Pengxing Li, Zixuan Zheng, Jingjing Shen, Zhisheng Xiao, Qian Chen
Zitieren
APA
Kang, Z., Chen, L., Li, P., Zheng, Z., Shen, J., Xiao, Z., Miao, Y., Yang, Y., & Chen, Q. (2025). A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis. Science Advances, 11(11). https://doi.org/10.1126/sciadv.adt0341
Vancouver
Kang Z, Chen L, Li P, Zheng Z, Shen J, Xiao Z, et al. A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis. Science Advances. 2025;11(11). doi:10.1126/sciadv.adt0341
BibTeX
@article{Kang2025,
author = {Kang, Zheyu and Chen, Linfu and Li, Pengxing and Zheng, Zixuan and Shen, Jingjing and Xiao, Zhisheng and Miao, Yu and Yang, Yang and Chen, Qian},
title = {A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {11},
doi = {10.1126/sciadv.adt0341}
}
EUVIMED